Back to search
Immune-Mediated Colitis
Clinical trial pipeline · Data from ClinicalTrials.gov
See which Immune-Mediated Colitis trials you may qualify forClinical trial pipeline · Data from ClinicalTrials.gov
See which Immune-Mediated Colitis trials you may qualify forMultiple retrospective studies suggest that the administration of corticosteroids to treat irAEs is safe, and does not compromise efficacy of ICI therapy in can…
The goal of this clinical trial is to determine the outcome of patients with immune checkpoint inhibitor-mediated diarrhea/colitis (IMC) treated with faecal mic…
UC is a chronic, idiopathic form of intestinal inflammatory disease (IBD) that affects the colon, most commonly afflicting adults aged 30-40 years and resulting…
This is a multicentric, observational study, including all European centres willing to take part. The multicentre nature is necessary for enhancing the generali…
The proposed study is part of a PNRR 2022 project (call "Non-Communicable Chronic Diseases (NCDs) with high impact on healthcare and social assistance systems,"…
Glucocorticoids are important in the treatment of many inflammatory, allergic, immunologic, and malignant disorders. However, the adverse effects of systemic co…
The purpose of this study is to assess the effectiveness of ustekinumab on extra-intestinal manifestations (EIMs) and immune-mediated inflammatory diseases (IMI…
This is a single-arm pilot study evaluating the efficacy and safety of tofacitinib in cancer patients with immune-related colitis from immune checkpoint inhibit…